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Abstract
Hox proteins are conserved homeodomain transcription factors known to be crucial regulators of animal
development. As transcription factors, the functions and modes of action (co-factors, target genes) of Hox proteins
have been very well studied in a multitude of animal models. However, a handful of reports established that Hox
proteins may display molecular activities distinct from gene transcription regulation. Here, we reveal that Hoxa2
interacts with 20S proteasome subunits and RCHY1 (also known as PIRH2), an E3 ubiquitin ligase that targets p53
for degradation. We further show that Hoxa2 promotes proteasome-dependent degradation of RCHY1 in an ubiquitin-
independent manner. Correlatively, Hoxa2 alters the RCHY1-mediated ubiquitination of p53 and promotes p53
stabilization. Together, our data establish that Hoxa2 can regulate the proteasomal degradation of RCHY1 and
stabilization of p53.
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Introduction
Hoxa2 belongs to the mammalian Hox genes family that
encodes 39 highly conserved homeodomain transcription
factors mainly involved in embryonic development but also in a
large number of pathological processes [1-4]. The
developmental roles of Hox proteins have been extensively
studied over the past decades and revealed to cover axial
patterning of the embryo [5,6], limb formation [7,8],
organogenesis processes [9-11] or haematopoiesis [12,13].
At the molecular level, the transcriptional activities of Hox
proteins have been well documented and a handful of Hox
transcriptional cofactors could be identified, such as Pbx or
Meis proteins that belong to the TALE proteins family [14,15].
Hox transcriptional targets were also functionally identified
through transcriptomic screenings [16,17] and chromatin
immunoprecipitation assays [18-21].
In parallel to their transcriptional activity, some Hox proteins
have been involved in non-transcriptional processes. First, Hox
proteins have been associated with translational functions.
HOXA9 and HOXA13, for example, interact with the initiation
factor of translation, eIF4E [22,23]. Interaction between HOXA9
and eIF4E stimulates mRNA transport by eIF4E and translation
efficiency [22]. Second, Hox proteins have been involved in
DNA double-stranded break (DSB) repair. HOXB7, for
instance, interacts with two DNA repair proteins, Ku70/80,
involved in nonhomologous end joining pathway (NHEJ) of
DSB repair and confers resistance to DNA damage on
irradiated cells [24]. Third, homeodomain proteins can cross
biological membranes [25,26]. This feature, coupled with the
possibility to be secreted into the extracellular milieu might
confer to homeodomain proteins a direct cell-signalling activity.
Finally, Hox proteins have been shown to play a crucial role in
cell cycle regulation through the control of DNA replication.
HOXD13, for example, binds DNA replication origins, primarily
during G1 phase of the cell cycle, promotes the assembly of
pre-replication complexes and induces DNA synthesis [27].
Such a role in cell cycle has also been suggested for HOXC10
[28] or Hoxb4, which has been associated with hematopoietic
cell proliferation [29]. In this context, Hoxb4 takes part in an E3
ubiquitin ligase complex that specifically recognizes Geminin,
an anti-replicative protein, and induces its degradation [30].
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Therefore, it appears that Hox proteins may not simply be
active as transcription factors. However, evidence about the
molecular activities of Hox proteins in a non-transcriptional
context remain sparse and need more extensive investigation.
Hoxa2 has been involved in rostral hindbrain and neural
crest patterning. Knock-out mice for Hoxa2 display defects in
hindbrain segmental identity affecting the second and third
rhombomeres [31-33]. At this level, Hoxa2 has been shown to
be crucial for axon guidance and the building of sensorimotor
circuitry connecting the brainstem to upper nervous centres
[33,34]. Hoxa2 is also essential for the identity of neural crest
cells migrating from the hindbrain to the second branchial arch,
which participate to the formation of skeletal derivatives notably
within the middle ear [31,32].
At the molecular level, some Hoxa2 transcriptional targets
such as Lmo1, Meox1, Lhx6, Ptx1, Robo2 or Six2 have been
reported [35-39]. However, only Six2, Robo2 and Hoxa2 itself,
have been characterized so far as direct Hoxa2 target genes
[35,39-41]. A genome-wide survey of Hoxa2-bound sequences
in the second branchial arch correlated to transcriptomic
analyses allowed identifying large sets of candidate genes
under the immediate control of Hoxa2 [18]. As interaction
partners, only TALE proteins could be directly related to Hoxa2
molecular function [40] and a few candidate Hoxa2-interacting
proteins have been identified mainly in the context of high-
throughput experiments [42].
At the cellular level, it has been reported that Hoxa2 inhibits
cell differentiation in the chondrogenic context and seems to be
involved in cell migration [43-45]. Hoxa2 also inhibits
differentiation of oligodendrocytes and, in addition, promotes
their proliferation [46,47]. Conversely, Hoxa2 has been
proposed to display an anti-proliferative activity during lung
development [48]. However, the functional connection between
molecular targets, cellular activities and developmental roles of
Hoxa2 remains largely to be unveiled, as it is the case for other
Hox proteins.
In this study, we identified three unexpected interaction
partners for Hoxa2: the RING finger and CHY zinc finger
domain-containing protein 1, RCHY1 (also known as PIRH2),
and 20S proteasome subunits PSMA3 and PSMB2. RCHY1 is
an E3 ubiquitin ligase that has been mainly involved in cell
cycle and apoptosis through its activity towards the key cell
cycle regulators p53 and p27Kip1 [49,50]. As a consequence of
the interaction between Hoxa2 and RCHY1, we further show
that Hoxa2 specifically triggers the degradation of RCHY1 in an
ubiquitin-independent and proteasome-dependent manner, and
in turn stabilizes p53 protein level. Together, our results show
that Hoxa2 is involved in negative regulation of the RCHY1 E3
ubiquitin ligase and identify a new molecular pathway
connecting Hox proteins to the p53 protein homeostasis.
Results
Hoxa2 interacts with RCHY1, PSMA3 and PSMB2
To gain an insight into the mode of action of Hoxa2, we
performed a stringent high-throughput GAL4-based yeast two-
hybrid screen optimized for the testing of the entire human
ORFeome [51,52]. The human ORFeome v3.1 consists of an
extensive set of cloned open reading frames derived from the
human genome and corresponding to 10,214 human protein
coding genes [52]. Using Hoxa2 both as a bait and prey, we
screened the 12,212 open reading frames (ORFs) of the
human ORFeome v3.1 and identified a short isoform of the
RING finger and CHY zinc finger domain-containing protein 1
(RCHY1, better known as PIRH2), the proteasome subunit
alpha type-3 (PSMA3) and the proteasome subunit beta type-2
(PSMB2) as Hoxa2-interacting proteins. These results were
then confirmed by retransforming expression vectors for these
potential partners into yeast and retesting them against Hoxa2
(Figure 1A).
To validate these results by co-precipitation experiments in
mammalian cells, we constructed expression vectors for N-
terminally triple-FLAG-tagged Hoxa2 (FLAG-Hoxa2) and N-
terminal glutathione S-transferase (GST)-PSMA3, -PSMB2 or -
RCHY1 (full length) fusion proteins. These vectors were then
co-transfected in HEK293T cells and glutathione-agarose
beads were used to co-purify GST-fused interactors and FLAG-
Hoxa2. As a positive control, we chose to use Hoxa1 dimer
formation which had already been reported by co-precipitation
[53,54] (Figure 1B). Cells transfected with FLAG-Hoxa2 alone
were used as negative control. In the absence of expression
vector for GST-tagged protein, no or weak background binding
of FLAG-Hoxa2 was detected (Figure 1B). However, we
successfully retrieved FLAG-Hoxa2 from cells co-expressing
GST-PSMA3 and GST-PSMB2, therefore validating these
proteins as Hoxa2 interaction partners (Figure 1B). Conversely,
we failed to recover FLAG-Hoxa2 upon GST-RCHY1 co-
expression (data not shown). While verifying that the fusion
proteins were properly expressed in transfected cells, we were
surprised to observe that, compared to cells transfected with
the GST-RCHY1 vector alone, cells co-transfected with FLAG-
Hoxa2 expression vector showed barely detectable weak GST-
RCHY1 protein levels. This therefore indicated that expression
of Hoxa2 had a negative effect on GST-RCHY1 protein
accumulation. Since the GST-RCHY1 expression construct
was based on a constitutively active CMV promoter, we
hypothesized that the influence of Hoxa2 on the RCHY1
protein level was most likely due to an impact on RCHY1
protein stability.
Hoxa2 induces RCHY1 degradation in a proteasome-
dependent way
Since we suspected that RCHY1 protein stability was
affected in presence of Hoxa2, we used a proteasome inhibitor,
MG132, as the proteasome mediates one of the two main
pathways of intracellular protein degradation. We exposed
HEK293T cells to 1 µM of MG132, or to DMSO alone as a
negative control, 24 hours after transfection, during 15 hours.
In these conditions, high protein levels were observed for both
FLAG-Hoxa2 and GST-RCHY1 in MG132 treated cells (Figure
1C). We next performed affinity co-purification assays using
glutathione-agarose beads and validated RCHY1 as an
interaction partner for Hoxa2 (Figure 1C).
The striking observation regarding RCHY1 protein levels in
these assays focused our attention on the degradation pathway
of RCHY1. To confirm the suspected involvement of Hoxa2 in
Hoxa2 and RCHY1
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Figure 1.  Hoxa2 interacts with RCHY1, PSMA3 and PSMB2.  (A) Yeast two-hybrid analyses with Hoxa2 as prey (AD-Hoxa2) and
PSMA3, PSMB2 or RCHY1 as bait (DB-PSMA3, DB-PSMB2, DB-RCHY1). Yeast transformed with expression vectors for GAL4-DB
and GAL4-AD fusion proteins were mated on complete medium (YPD) and transferred on synthetic dropout medium plates lacking
histidine, leucine and tryptophan (-L-W-H) to select diploids in which the GAL1-HIS3 reporter is activated as a consequence of
hybrid proteins interaction. Negative control plates were composed of synthetic dropout medium containing cycloheximide and
lacking histidine and leucine (-L+W-H+C) and positive controls for matings were transferred on synthetic dropout medium plates
lacking leucine and tryptophan (-L-W). (B) Co-precipitation assays. HEK293T cells were co-transfected with expression vectors for
FLAG- and GST-tagged Hoxa1 as a positive control, for FLAG-tagged Hoxa2 alone as a negative control and for FLAG-tagged and
GST-tagged PSMA3 or GST-tagged PSMB2. Forty-eight hours after transfection, cell lysates were subjected to western blotting
analyses to detect protein expression (beta-actin used as a protein load control). Protein interactions were then verified by co-
precipitation on glutathione beads directed toward the GST tag. Eluted proteins were analysed by western blotting using M2
antibody to detect the presence of FLAG-tagged Hoxa2 (CoP). (C) Similar co-precipitation assays using MG132 or DMSO treated
HEK293T cells reveal FLAG-tagged Hoxa2 and GST-tagged RCHY1 interaction upon proteasome inhibition.
doi: 10.1371/journal.pone.0080387.g001
Hoxa2 and RCHY1
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RCHY1 proteasomal degradation, we co-transfected vectors
for wild-type Hoxa2 and FLAG-tagged RCHY1 proteins in
HEK293T. Cells were then treated with 1µM of MG132, or
DMSO, during 15 hours. As shown in Figure 2A, when wild-
type Hoxa2 and FLAG-tagged RCHY1 expression vectors were
co-transfected, a severe depletion in FLAG-RCHY1 protein
could be observed in comparison with the accumulation of
FLAG-RCHY1 when it is expressed alone (Figure 2A). In
addition, this Hoxa2-associated reduction in FLAG-RCHY1
protein levels was rescued by MG132 treatment thereby
confirming a proteasome-dependent degradation of RCHY1
(Figure 2A). As the primary function of RCHY1 is to be an E3
ubiquitin ligase, it has also to be noticed that, contrary to what
one might expect consequently to its interaction with Hoxa2, no
significant decrease in Hoxa2 protein level could be observed
upon co-expression with FLAG-RCHY1 (Figure 2A).
Proteasomal degradation occurs both in the nucleus and
cytoplasm. As RCHY1 can be found in both subcellular
compartments [55,56], the next question was to determine if we
could observe a change in subcellular localization upon co-
expression with Hoxa2. HEK293T cells were co-transfected
with expression vectors for FLAG-Hoxa2 and GST-RCHY1 and
treated with 1µM of MG132 for 15 hours. Cells were then
processed to detect FLAG- and GST-tagged proteins and
observed under confocal microscopy to characterize protein
subcellular localization. As expected, when expressed alone
GST-RCHY1 was present both in the nucleus and cytoplasm
and it was more abundant when cells were treated with MG132
than in untreated cells (Figure 2B). A classical nuclear staining
for Hoxa2 and a reduced staining for RCHY1 were observed in
untreated cells co-expressing FLAG-Hoxa2 and GST-RCHY1
(Figure 2B). Finally, corresponding MG132-treated cells
presented a nuclear co-localization for Hoxa2 and RCHY1, and
no significant change in their respective intracellular distribution
could be detected (Figure 2B). Since Hoxa2 and RCHY1 co-
localize mainly in the nucleus, it can be assumed that their
interaction, and the subsequent RCHY1 degradation, takes
place in this subcellular compartment.
Hoxa2-induced RCHY1 degradation is ubiquitin
independent
As poly-ubiquitination is the main pathway for proteasomal
degradation, and the only one currently known for RCHY1
degradation [49], we addressed the possibility that Hoxa2
triggers an ubiquitin-dependent RCHY1 decay. To test this, we
co-transfected HEK293T cells with expression vectors for 6His-
tagged ubiquitin octamer and FLAG-RCHY1, with or without
expression vector for wild-type Hoxa2. Again, cells were
treated with 1µM of MG132 for 15 hours to inhibit the
proteasome. Protein lysates were then purified for 6His-
ubiquitinated proteins using NiNTA-beads and attached
proteins were then loaded on SDS-PAGE to detect RCHY1
poly-ubiquitinated forms. Unexpectedly, in the presence of
Hoxa2, a reduced RCHY1 poly-ubiquitination profile was
observed, indicating that the Hoxa2-induced RCHY1
degradation is ubiquitin-independent. Moreover, as less
RCHY1 ubiquitinated forms were detected in the presence of
Hoxa2, this suggests that the poly-ubiquitination of RCHY1 is
altered upon Hoxa2 interaction (Figure 2C). These results were
further confirmed with GST-RCHY1 (data not shown).
The Hoxa2 homeodomain is essential for the Hoxa2-
mediated RCHY1 degradation
To further provide mechanistic insights into the Hoxa2-
mediated RCHY1 degradation, we performed experiments
using mutant Hoxa2 proteins. A first Hoxa2 mutant harbours
amino-acid substitutions in its homeodomain (Hoxa2KQN-RAA). In
this mutant, the substituted glutamine and asparagine define
two critical amino acid residues involved in the Hox-DNA
interactions established by the third helix of the homeodomain
which are shared by all Hox proteins [57]. The Hoxa2KQN-RAA
protein is therefore DNA-binding defective [40]. A second
mutant displays substitutions in the short hexapeptide motif
involved in the interaction of Hoxa2 with the Pbx proteins
(Hoxa2WM-AA). As previously shown, these Hoxa2 variants are
transcription defective [40]. Co-precipitation assays from
MG132 treated HEK293T cells transfected for Flag-Hoxa2,
Flag-Hoxa2KQN-RAA or Flag-Hoxa2WM-AA and GST-RCHY1 or a
GST control revealed that both mutants were still able to bind
to RCHY1 (Figure 3A). However, while Hoxa2 and Hoxa2WM-AA
GST fusion were prominent in inducing degradation of Flag-
RCHY1, the homeodomain mutant was not. Co-expression of
Flag-RCHY1 and either GST-Hoxa2 or GST- Hoxa2WM-AA
resulted in the disappearance of the Flag-RCHY1 in untreated
cells where the proteasome was active, whereas upon
expression of GST-Hoxa2KQN-RAA, the level of Flag-RCHY1 was
unaffected (Figure 3B).
Since Hox proteins share important sequence similarities, in
particular at the level of the homeodomain, we tested whether
another Hox protein, namely Hoxa1, also displayed the ability
to interact with and provoke the degradation of RCHY1. Co-
precipitation from HEK293T transfected cells expressing Flag-
Hoxa1, and GST-RCHY1 or a GST control supported that
Hoxa1 shares the ability to bind to RCHY1 (Figure 4A).
Remarkably however, unlike Hoxa2, expression of a Hoxa1
fusion protein did not affect the level of RCHY1 in either
MG132 or untreated cells (Figure 4B). This supports that
although able to contact RCHY1, Hoxa1 is not proficient in
targeting RCHY1 to proteasomal degradation.
Hoxa2 inhibits RCHY1-dependent ubiquitination of p53
and stabilizes p53 protein level
p53 turnover has recently been revealed to occur through
ubiquitination by RCHY1 and subsequent proteasomal
degradation [49]. Since we observed that Hoxa2 can induce
RCHY1 degradation, to get an insight into the possible
biological consequences of the Hoxa2-RCHY1 interaction, we
next examined the effect of Hoxa2 on p53 ubiquitination. We
co-transfected cells with expression vectors for FLAG-RCHY1,
p53 R72 variant (dbSNP: rs1042522) and 6His-tagged ubiquitin
octamer, with or without a vector for wild-type Hoxa2. Cells
were then treated with MG132 and protein lysates were purified
using NiNTA-beads. Purified proteins were loaded on a SDS-
PAGE gel to detect p53 poly-ubiquitinated forms. In the
presence of Hoxa2, we observed less p53-ubiquitinated forms
indicating that Hoxa2 negatively affects RCHY1-dependent p53
Hoxa2 and RCHY1
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Figure 2.  Hoxa2 induces proteasome-dependent ubiquitin-independent RCHY1 degradation and colocalizes with RCHY1 in
the nucleus.  (A) HEK293T cells were co-transfected with expression vectors for Hoxa2 and FLAG-tagged RCHY1, and treated
with MG132 proteasome inhibitor, or DMSO. Cell lysates were loaded on SDS-PAGE for proteins separation and western blotting
(beta-actin used as a protein load control). (B) FLAG-Hoxa2 and GST-RCHY1 colocalize in the nucleus. HEK293T cells were co-
transfected with FLAG-tagged Hoxa2 and GST-tagged RCHY1, treated with MG132 proteasome inhibitor, or DMSO, and subjected
to immunocytochemistry with anti-FLAG M2 antibody (green) and anti-GST antibody (red). Nuclei were stained with DAPI (blue). (C)
Ubiquitination assays for FLAG-tagged RCHY1. HEK293T cells were co-transfected with indicated expression vectors and treated
with MG132. Cells were then lysed and 6His-ubiquitin conjugated proteins were purified using Ni-NTA beads. Purified proteins and
cell lysates were analysed by western blotting using M2 antibody to detect ubiquitinated forms of FLAG-tagged RCHY1. Lysate
samples were loaded on a SDS-PAGE to verify protein levels prior to purification (Input; beta-actin was used as a protein load
control). Lane numbering under the gels identifies cell samples. I: input sample; P: Ni-NTA purified sample.
doi: 10.1371/journal.pone.0080387.g002
Hoxa2 and RCHY1
PLOS ONE | www.plosone.org 5 November 2013 | Volume 8 | Issue 11 | e80387
Figure 3.  The integrity of the Hoxa2 homeodomain is required for the Hoxa2-induced RCHY1 decay.  (A) Co-precipitation
assays involving mutant forms of Hoxa2. HEK293T cells were cotransfected with expression vectors for FLAG-tagged Hoxa2
(FLAG-Hoxa2wt), FLAG-tagged Hoxa2KQN-RAA (FLAG-Hoxa2KQN-RAA), FLAG-tagged Hoxa2WM-AA (FLAG-Hoxa2WM-AA), GST-
tagged RCHY1 and GST proteins, and treated with the proteasome inhibitor MG132. Forty-eight hours after transfection, cell lysates
were subjected to western blotting (input) and protein interactions were verified by co-precipitation on glutathione beads directed
toward the GST tag. Eluted proteins were analysed by western blotting using the M2 anti-FLAG antibody (CoP). (B) Amino acid
substitutions in the Hoxa2 homeodomain abolish the Hoxa2-mediated degradation of RCHY1. HEK293T cells were transfected with
expression vectors for FLAG-tagged RCHY1 (FLAG-RCHY1) and GST-tagged Hoxa2 (GST-Hoxa2wt, GST-Hoxa2KQN-RAA, GST-
Hoxa2WM-AA) proteins. Cells were then treated for proteasome inhibition (MG132) and compared to untreated controls (DMSO) for
the decay of FLAG-RCHY1 revealed by western blot detection. Detection of beta-actin was used as a protein load control.
doi: 10.1371/journal.pone.0080387.g003
Hoxa2 and RCHY1
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ubiquitination in MG132 treated HEK293T cells (Figure 5A). As
cells were treated with MG132, these results suggest that
Hoxa2 inhibits RCHY1 ubiquitin ligase activity as such. To
further investigate the effect of Hoxa2 on p53 stabilization, we
next transfected wild-type Hoxa2 expression vector in PA1
cells. In the presence of Hoxa2, we observed a stabilization of
endogenous p53 protein level (Figure 5B). Together, these
results indicate that Hoxa2 negatively affects RCHY1 stability
and RCHY1-dependent ubiquitination of p53 thereby inducing a
stabilization of p53 and an increase in p53 protein level.
Discussion
While Hox proteins are well established transcription factors
acting as cornerstones in the regulation of developmental
processes or in some instances of oncogenesis, the molecular
interactions underlying their functions have been rather poorly
investigated and have been basically focused on their
transcriptional activity. Nevertheless, a growing body of
evidence supports that Hox proteins could be involved in other
processes like translational regulation, DSB repair or DNA
replication [22,24,27,30]. Here, we have characterised a new
role of Hoxa2 in the proteasomal protein degradation pathway.
We identified the RING finger and CHY zinc finger domain-
containing protein 1, RCHY1, and two 20S core proteasome
subunits, PSMA3 and PSMB2, as novel interaction partners for
Hoxa2. We further showed that Hoxa2 induces proteasome-
dependent RCHY1 degradation, independently of the ubiquitin
system, and promotes p53 protein stabilization. We thus
provide evidence for a new molecular mechanism that possibly
links Hox protein activity to p53-related pathways.
Our results show that Hoxa2 interacts with RCHY1, an E3
ubiquitin ligase involved in specific degradation of key cell cycle
regulators such as p53 or p27Kip1 [49,50]. This interaction
promotes proteasomal degradation of RCHY1 and we provide
data supporting that this degradation takes place independently
of the ubiquitin system. Such a proteasomal degradation
pathway independent of the ubiquitin system has already been
reported for various proteins and, for some of them, the activity
of the isolated 20S proteolytic core particle has been directly
involved in the mechanism [58-60]. Similarly, our results show
interaction between Hoxa2 and some subunits of the 20S core
particle such as PSMA3, for example, which has been directly
involved in the ubiquitin-independent degradation of p21Cip1 or
Rb [58,61], indicating that a similar mechanism could be
involved in Hoxa2-mediated degradation of RCHY1. Since we
observed a nuclear co-localization of Hoxa2 and RCHY1 upon
proteasome inhibitor treatment, we propose that Hoxa2
interacts with 20S core proteasome to directly induce nuclear
RCHY1 proteasomal degradation in an ubiquitin-independent
manner.
Distinct proteins had already been proposed to be involved in
the turnover of RCHY1 [56,62,63]. However, despite its crucial
role in cancer and other pathologies [64-66], only two
physiological factors have been reported to negatively regulate
RCHY1 at the protein level: RCHY1 itself [49] and calmodulin-
dependent protein kinase II (CaMKII) [63]. Indeed, RCHY1 may
be self-ubiquitinated or subject to posttranslational
Figure 4.  Hoxa1 does not promote RCHY1 degradation.  (A) Co-precipitation assays involving Hoxa1. HEK293T cells were
cotransfected with expression vectors for FLAG-tagged Hoxa1 (FLAG-Hoxa1), GST-tagged RCHY1 and GST proteins, and treated
with the proteasome inhibitor MG132. Forty-eight hours after transfection, cell lysates were subjected to western blotting (input) and
protein interactions were verified by co-precipitation on glutathione beads directed toward the GST tag. Eluted proteins were
analysed by western blotting using the M2 anti-FLAG antibody (CoP). (B) Hoxa1 does not promote the degradation of RCHY1.
HEK293T cells were transfected with expression vectors for FLAG-tagged RCHY1 (FLAG-RCHY1) and GST-tagged Hoxa1 (GST-
Hoxa1) proteins. Cells were then treated for proteasome inhibition (MG132) and compared to untreated controls (DMSO) for the
decay of FLAG-RCHY1 revealed by western blot detection. Detection of beta-actin was used as a protein load control.
doi: 10.1371/journal.pone.0080387.g004
Hoxa2 and RCHY1
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phosphorylation by CaMKII both leading to a decrease in
RCHY1 protein levels [49,63]. Here, we thus identify Hoxa2 as
a new factor involved in negative RCHY1 protein regulation. In
addition to the enhanced turnover of RCHY1 by Hoxa2, we
also observed a decrease in RCHY1 and p53 ubiquitination
profiles in the presence of Hoxa2. This suggests that Hoxa2
interaction with RCHY1 also inhibits overall RCHY1 ubiquitin
ligase activity. At the molecular level, the ability to promote
RCHY1 degradation (while not its binding) relies on the
integrity of the homeodomain. However, although necessary to
induce RCHY1 decay, the homeodomain determinants should
not be sufficient. Indeed, although sharing a highly conserved
homeodomain, the Hoxa1 protein could not stimulate RCHY1
decrease.
Figure 5.  Hoxa2 inhibits RCHY1-dependent ubiquitination of p53 and stabilizes p53.  (A) Ubiquitination assays for p53.
HEK293T cells were co-transfected with indicated plasmids and treated with MG132. Cells were lysed and Ni-NTA beads were used
to pull down 6His-ubiquitin-conjugated proteins. Proteins were separated by SDS–PAGE and western blotting was performed using
an anti-p53 antibody to detect ubiquitinated forms of p53. Lysate samples were loaded on a SDS-PAGE to verify protein levels prior
to purification (Input; beta-actin was used as a protein load control). Lane numbering under the gels identifies cell samples. I: input
sample; P: Ni-NTA purified sample. (B) p53 protein stabilization by Hoxa2. PA1 cells were transfected with indicated plasmids and
treated with MG132, or DMSO as control. Cells were lysed, proteins were separated by SDS-PAGE and western blot detection was
performed with indicated antibodies.
doi: 10.1371/journal.pone.0080387.g005
Hoxa2 and RCHY1
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Our results support a model in which Hoxa2 acts as a
stabilizer for p53 protein level, via its negative effect on
RCHY1. This could not be expected from the known roles of
Hoxa2. Indeed, p53 is known to be mainly involved in cell cycle
arrest, senescence and apoptosis [67]. Thus, a p53
stabilization would, at a first glance, induce cell cycle arrest,
senescence and/or increase in apoptosis, which is not in line
with Hoxa2 functional studies that led to postulate anti-
differentiation and pro-proliferative roles for Hoxa2 [43,46,68].
Nevertheless, besides its role in cell cycle and apoptosis, p53
has also been involved in DNA repair. The p53 response to
DNA damage varies according to its subcellular localization,
the cell cycle status and the extent of DNA damage, from
apoptosis induction to DNA repair [69]. Efficient DNA repair is a
crucial requirement during embryonic development [70]. It
allows cells sustaining a high division rate, implying shorter cell
cycles, but preserving quality divisions essential for
developmental processes. In that context, analyses with the
KEGG PathwayFinder module from the R2 microarray analysis
and visualization platform (http://r2.amc.nl) allowed highlighting
a wide range of transcripts positively correlated to HOXA2
expression which correspond to genes involved in DNA repair
(data not shown). In support of this hypothesis, RCHY1 has
been shown to induce the degradation of PolH, a member of
the Y family translesion DNA polymerase involved in double-
strand break repair via homologous recombination [71,72]. In
addition, the study of the knock-out mouse for Rchy1 has
recently been published and confirmed its role in DNA repair
[73].
Molecular activities related to such basic cell processes as
DNA repair or protein turnover have already been described for
Hox proteins of distinct paralog groups [24,30]. Hoxb4 has
been involved in DNA replication through a direct involvement
in an E3 ubiquitin ligase complex that targets Geminin for
degradation [30]. HOXB7 has been directly related to DNA
repair processes [24]. Considering the general involvement of
Hox proteins in the control of developmental processes and
their functional redundancy, it is tempting to propose that the
implication of Hox proteins in DNA repair processes and
protein degradation pathways could be more general than just
the matter of Hoxa2. Finally, while mutant Hoxa2 proteins
assayed for their ability to induce RCHY1 degradation still
appear to interact with RCHY1, amino acid substitutions in the
Hoxa2 homeodomain critically impairs its impact on RCHY1
turn over. A similar observation was reported for the
involvement of Hoxb4 in the E3 ubiquitin ligase complex active
towards Geminin. A single amino acid substitution in the Hoxb4
homeodomain was sufficient to impair its ability to enhance the
poly-ubiquitination activity although the mutant protein was still
able to form the complex [30].
Conclusions
In conclusion, we have demonstrated that the 20S
proteasome subunits PSMA3 and PSMB2 as well as the E3-
ubiquitin-ligase RCHY1 are direct interactors of Hoxa2. We
further showed that Hoxa2 promotes the proteasome-
dependent and ubiquitin-independent degradation of RCHY1
which in turn is correlated to p53 stabilization. The RCHY1




Expression vector for wild-type Hoxa2 was described
previously [38]. Sequences coding for the wild-type Hoxa2, and
mutant Hoxa2KQN-RAA and Hoxa2WM-AA proteins [40] were PCR-
amplified and inserted into pDON223 vector using the
Gateway® Technology from Invitrogen. The resulting entry
plasmids were confirmed by DNA sequencing. Entry vector
was then used to generate yeast expression vectors for AD-
and DB-tagged Hoxa2 with pDEST-AD and pDEST-DB
destination vectors (Gateway®, Invitrogen); mammalian
expression vectors for FLAG-tagged Hoxa2, Hoxa2KQN-RAA and
Hoxa2WM-AA, with v1899 destination vector (for a N-terminal
triple FLAG-tag fusion [74]); and mammalian expression
vectors for GST-tagged Hoxa2, Hoxa2KQN-RAA and Hoxa2WM-AA
proteins (pDEST-GST N-terminal [75]). Entry vectors for
PSMA3, PSMB2 and full length RCHY1 are from the
hORFeome v3.1 [76] and were used to generate destination
mammalian expression vectors for N-terminal GST fusion
proteins (pDEST-GST N-terminal [75]). The coding sequence
for RCHY1 was also transferred into v1899 destination vector
to produce a FLAG-tagged RCHY1. Expression vectors for N-
terminal triple FLAG and N-terminal GST fusion Hoxa1 have
been described elsewhere [54]. Expression vectors for 6His-
tagged ubiquitin and p53R72 were kindly offered by Sonia Lain
(University of Dundee, UK) and Patrick Dumont (Université
catholique de Louvain, Belgium), respectively. In each
transfection experiment, to keep the amount of transfected
DNA constant, the pCAT®-Control vector (GenBank:
X65321.2; Promega Corp.) coding for a Chloramphenicol
acetyltransferase was invovled as a neutral control expression
vector.
Two-Hybrid screening
AD-vectors and DB-vectors were transformed into S.
cerevisiae strains Y8800 (MATa) and Y8930 (MATα),
respectively, using a one-step transformation protocol [77].
Yeast cells were plated onto synthetic dropout medium lacking
tryptophan or leucine, respectively. Transformed yeasts were
mated overnight at 30°C on solid medium containing yeast
extract, peptone and dextrose (YEPD). Yeasts were then
transferred on synthetic dropout medium plates lacking
histidine, leucine and tryptophan to select diploids in which the
GAL1-HIS3 reporter is activated. Control plates for
autoactivation were composed of synthetic dropout medium
containing cycloheximide (1 mg/L) and lacking histidine and
leucine. Mating controls were plated on synthetic dropout
medium lacking leucine and tryptophan.
Cell culture and treatment
Culture cells were maintained at 37°C, in a humidified
atmosphere with 5% C02. HEK293T cell line was grown in
Hoxa2 and RCHY1
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Dulbecco’s Modified Eagle Medium (D-MEM) with Gultamax-II
(#31965-023, GIBCO) supplemented with 10% fetal bovine
serum (#10270-106, Invitrogen), 1% penicillin-streptomycin
(#15140-122, GIBCO) and 1% sodium pyruvate MEM 100 mM
(#1111360-039, GIBCO). PA1 cells were maintained in
Dulbecco’s Modified Eagle Medium (D-MEM) with high glucose
and 25 mM HEPES (#42430, GIBCO) supplemented with 10%
fetal bovine serum (#10270-106, Invitrogen) and 1% penicillin-
streptomycin (#15140-122, GIBCO). For transfections, plasmid
constructs were transfected with jetPRIMETM transfection
reagent (#114-07, Polyplus-transfection) according to the
manufacturer's instructions. For proteasome inhibition, 24h
after transfection, cells were treated with 10 µM MG132 in
DMSO (#474790, Calbiochem), or with DMSO as control,
during 15 hours.
Protein expression analysis
Thirty-nine hours after transfection, cells were lysed for
20-30 min at 4°C in ice-cold RIPA buffer (250 mM NaCl, 50 mM
TrisHCl pH7.5, 1% Nonidet P40, 0.5 % NaDeoxycholate, 0.1 %
SDS, 1 mM EDTA). Lysates were then sonicated three times
during 30 seconds and centrifuged. Supernatants were
recovered and equal amounts of proteins (30µg) were boiled 5
minutes at 95°C in Laemmli loading buffer for SDS-PAGE (10%
SDS, 50% glycerol, 250 mM Tris-HCl pH 6.8, 500 mM DTT,
0.5% bromophenol blue) and loaded on SDS-PAGE for
electrophoresis. Proteins were then transferred onto a
nitrocellulose membrane (Hybond™-C, #RPN303C, Amersham
Biosciences). Immunoblots were performed using the SNAP
i.d. protein detection system (Millipore). Membranes were
blocked in 0.5% fatty acid-free BSA solution (#A6003-10G,
Sigma). Anti-FLAG primary antibody (M2) (#F1804, Sigma)
was used at 1:500 dilution, anti-GST primary antibody (GST-2)
(#G1160, Sigma) was used at 1:300 dilution, anti-Hoxa2
primary antibody (#H9665 Sigma) was used at 1:500 dilution
and anti-p53 primary antibody (Ab-6) (DO-1) (#OP43,
Calbiochem) was used at 1:750 dilution. Goat anti-mouse
secondary antibody was HRP conjugated and used at 1:3000
dilution (#sc-2005, Santa Cruz). For beta-actin detection, HRP
conjugated anti-beta-actin was used at 1:3000 dilution
(#A3854, Sigma). Finally, membranes were treated for a
chemiluminescence detection system (#NEL104001EA,
PerkinElmer) and exposed to a photographic film. For multiple
hybridizations, membranes were rinsed 5 min in water, stripped
in NaOH 0.2M for 10 min, rinsed again 5 min with water and re-
analysed by western blotting.
Protein co-precipitation
HEK293T cells were transiently transfected with vectors for
FLAG-tagged-Hoxa2 variants and GST-tagged candidate
interaction partners. Thirty-nine hours after transfection cells
were lysed for 30 min at 4°C in ice-cold IPLS lysis buffer (0.5%
NP-40, 20 mM Tris-HCl pH 7.5, 0.5 mM EDTA, 120 mM NaCl,
10% glycerol) including protease inhibitor cocktail from Roche
(#11873580001, Roche). Cells lysates were centrifuged for 5
min at 16000 g at 4°C. Supernatants were recovered and
samples were incubated with rotation overnight at 4 °C with
glutathione-agarose beads (#G4510, Sigma) pre-washed three
times with ice-cold IPLS lysis buffer. Beads were washed three
times with ice-cold IPLS. Beads were supplemented with
Laemmli loading buffer for SDS-PAGE (10% SDS, 30%
glycerol, 350 mM Tris-Cl pH 6.8, 600 mM DTT, 0.1%
bromophenol blue) and boiled 5 minutes at 95°C. Samples
were centrifuged and loaded on denaturing SDS-PAGE gel for
analysis by western blotting. As controls, in parallel to protein
co-precipitation, expression of fusion proteins in the samples
was confirmed by western blotting.
Immunocytochemistry
HEK293T cultured on glass cover slips were transiently
transfected with FLAG-tagged Hoxa2 and GST-tagged RCHY1
expression vectors and treated with MG132 proteasome
inhibitor 24h after transfection. After overnight treatment, cells
were rinsed in PBS solution and fixed for 30 min with 4%
formaldehyde in PBS. Cells were further blocked with 10% low-
fat milk in TBS-0.1% Triton X100 solution for 45 min at room
temperature, followed by over-night incubation in TBS-0.1%
Triton X100 solution at 4°C, with mouse anti-FLAG antibody
(M2) (#F1804, Sigma) and rabbit anti-GST (#G7781, Sigma)
used at 1:500 and 1:50 dilution, respectively. Cells were rinsed
three times for 30 min in TBS-0.1% Triton X100 solution and
incubated for 45 min at room temperature with FITC
conjugated anti-mouse (#sc-3699, Santa Cruz) and TRITC
conjugated anti-rabbit (#sc-2367, Santa Cruz) at 1:100 dilution
in TBS-0.1% Triton X100 solution. Cells were rinsed three
times and glass cover slips were mounted in Vectashield®-
DAPI medium (Vector laboratories). Slides were then analysed
by confocal microscopy (LSM710, Zeiss, Jena, Germany).
Ni-NTA-resin purification for ubiquitination analyses
MG132 treated cells were lysed with imidazole containing
cell lysis RIPA buffer (250 mM NaCl, 50 mM TrisHCl pH7.5, 1%
Nonidet P40, 0.5 % NaDeoxycholate, 0.1 % SDS, 1 mM EDTA,
20 mM Imidazole) including protease inhibitor cocktail from
Roche (#11873580001, Roche) for 20-30 min on ice. Lysates
were then sonicated three times during 30 seconds and
centrifuged. Supernatants were recovered and incubated with
Ni-NTA Sepharose beads (#2-3201-010, Westburg) at 4°C on
a rotating wheel for 2 hours. Beforehand, Ni-NTA Sepharose
beads (#2-3201-010, Westburg) were pre-washed three times
with ice-cold RIPA buffer (250 mM NaCl, 50 mM TrisHCl
pH7.5, 1% Nonidet P40, 0.5 % NaDeoxycholate, 0.1 % SDS, 1
mM EDTA) including protease inhibitor cocktail. After
incubation, beads were washed three times with imidazole
containing RIPA buffer supplemented with Laemmli loading
buffer for SDS-PAGE (10% SDS, 50% glycerol, 250 mM Tris-Cl
pH 6.8, 500 mM DTT, 0.5% bromophenol blue). Samples were
boiled 5 minutes at 95°C, centrifuged and loaded on denaturing
SDS-PAGE gel for analysis by western blotting. Anti-FLAG
primary antibody (M2) (#F1804, Sigma) was used at 1:500
dilution. Anti-p53 primary antibody (Ab-6) (DO-1) (#OP43,
Calbiochem) was used at 1:750 dilution. Goat anti-mouse
secondary antibody was HRP conjugated and used at 1:3000
dilution (#sc-2005, Santa Cruz).
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